Crossmark

Next-generation sequencing identifies monogenic diabetes in 16% of patients with late adolescence/adult-onset diabetes selected on a clinical basis: a cross-sectional analysis

Crossref DOI link: https://doi.org/10.1186/s12916-019-1363-0

Published Online: 2019-07-11

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

,

Donath, Xavier

Saint-Martin, Cécile

Dubois-Laforgue, Danièle

Rajasingham, Ramanan

Mifsud, François

Ciangura, Cécile

Timsit, José

Bellanné-Chantelot, Christine https://orcid.org/0000-0001-8415-6771
Funding

Funding for this research was provided by:

Assistance Publique - Hôpitaux de Paris (HAO11013 - NI11010, HAO11013 - NI11010)
License Information

Text and Data Mining valid from 2019-07-11

Version of Record valid from 2019-07-11
More Information

Article History

Received: 22 January 2019

Accepted: 10 June 2019

First Online: 11 July 2019

Ethics approval and consent to participate

: All participants and the parents of those < 18 years of age at the time of genetic testing gave written informed consent. The DNA bank and diagnostic database were declared to French health authorities in compliance with current legislation.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below